What's Happening with Sentinel

Inverse Probability of Exposure and Censoring Weights for Marginal Structural Models
Event Type: Webinar
Date: Thursday, September 30, 2021
Time: 12:00pm - 1:00pm EST

This presentation will introduce the basics of inverse probability of treatment weight and censoring weights and will discuss opportunities and challenges of using these approaches for causal effects of medication use in routinely collected healthcare utilization databases.
Register Here

About Sentinel

The U.S. Food and Drug Administration (FDA) leads the Sentinel Initiative. The main goal is to improve how FDA evaluates the safety and performance of medical products.

Learn More About Sentinel

How Sentinel Uses Data

The FDA uses Sentinel data to evaluate the safety of medical products. They also use Sentinel data to learn more about potential side effects.

Drug Assessments

How Sentinel Protects Privacy

Sentinel uses a distributed data approach. In this approach, data remain with the data owner, i.e., an insurance company. Also, data owners remove patient identifiers to protect privacy.

Privacy & Security

Where Sentinel Gets Its Data

Sentinel data come from existing sources. These includes insurance claims, electronic health records, and patient reports.

Who is Involved

What Data Sentinel Uses

Data from the health systems, insurance companies, or medical records can be used without personal information being shared to learn more about medical products.

Types of Data

Engage with Sentinel

An image of a virtual meeting screenshot.

Sentinel Initiative Public Workshop – 13th Annual

The 13th Annual Sentinel Initiative Public Workshop will convene on November 8-9, 2021. The workshop will be held as a 2-day virtual webinar from 10:00am – 2:00pm each day, and will provide an opportunity for attendees to discuss recent achievements and developments as well as engage with the broader community of patients, consumers, and scientific stakeholders.

View Details
Woman working with analytics at a computer

Methods, Data, & Tools

Sentinel has various methods and tools to support the evaluation of medical products. U.S. Food and Drug Administration (FDA) scientists use Sentinel data to complement their data and information.

Learn More

Data-Driven Impact

Approximately 70.6 million members are currently accruing new data in Sentinel
Key Database Statistics
192 scientific publications
Since the founding of the Sentinel Initiative in 2009, 192 scientific papers have been published
Scientific Publications
Since 2016, more than 30 Sentinel drug assessments have contributed to FDA regulatory actions or discussion
Drug Assessments

The Sentinel Community

Three images depicting people collaborating

Data Partners & Collaborators

The FDA gets data for the Sentinel System through its Data Partners. The Data Partners are the ones who access, maintain, and protect the data in a distributed system. The Sentinel Coordinating Center partners with a network of collaborators. This includes Data Partners and Collaborating Institutions. Together, they provide healthcare data and scientific, technical, organizational expertise.

Learn About the Community

Sentinel Structure

Three blue boxes representing the structure of Sentinel, including SOC, IC, CBOC

1. Community Building and Outreach Center (CBOC)
2. Innovation Center (IC)
3. Sentinel Operations Center (SOC)

These centers collaborate to advance regulatory science using the Sentinel System. However, each center operates independently and has a dedicated leadership team and staff. The three centers each carry out projects associated with their strategic objectives.

Explore the Centers